Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Bifidobacterium longum BB536 and Increased Normal Stool Consistency

Doses used in studies

CFU/day: 25 billion–50 billion (median 37.5 billion, IQR 25 billion–50 billion) — 1 study

Safety in these studies

Overall tolerabilityReported
No adverse events were reported in any group.
from: Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients recei

1 of 1 paper

Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding.
- 2013-12-10
- RCT · n = 206
- World Journal of Gastroenterology 19(14)
- - Junko Kondo
  - J. Xiao
  - A. Shirahata
  - Mieko Baba
  - Akie Abe
  - Koichi Ogawa
  - T. Shimoda
- PubMed: 23599642
- DOI: 10.3748/wjg.v19.i14.2162
17 Insights on
- Increased Normal Stool Consistency
- High evidence
- Rigorous Journal
BB536 ingestion increased the prevalence of normally formed stools.
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
BB536-H: approximately 5 × 10¹⁰ cfu; BB536-L: approximately 2.5 × 10¹⁰ cfu